{"nct_id":"NCT00701103","title":"Dose Escalation Trial of Dalotuzumab (MK-0646) in Advanced Solid Tumors and Multiple Myeloma (MK-0646-001)","status":"COMPLETED","status_verified_date":"2018-07","start_date":"2006-01-12","start_date_type":"ACTUAL","primary_completion_date":"2009-12-01","primary_completion_date_type":"ACTUAL","completion_date":"2009-12-01","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}